A detailed history of Kendall Capital Management transactions in Stryker Corp stock. As of the latest transaction made, Kendall Capital Management holds 782 shares of SYK stock, worth $280,519. This represents 0.09% of its overall portfolio holdings.

Number of Shares
782
Previous 782 -0.0%
Holding current value
$280,519
Previous $266,000 6.02%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 26, 2024

SELL
$253.85 - $299.46 $5,077 - $5,989
-20 Reduced 2.49%
782 $234,000
Q1 2023

May 11, 2023

BUY
$246.13 - $285.47 $197,396 - $228,946
802 New
802 $229,000
Q2 2022

Jul 29, 2022

SELL
$194.09 - $276.37 $186,714 - $265,867
-962 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$245.33 - $277.77 $36,799 - $41,665
-150 Reduced 13.49%
962 $257,000
Q4 2021

Jan 28, 2022

SELL
$236.63 - $276.44 $4,495 - $5,252
-19 Reduced 1.68%
1,112 $297,000
Q2 2021

Jul 30, 2021

SELL
$242.95 - $267.0 $3,644 - $4,005
-15 Reduced 1.31%
1,131 $294,000
Q1 2021

May 05, 2021

SELL
$221.01 - $248.82 $27,626 - $31,102
-125 Reduced 9.83%
1,146 $279,000
Q4 2020

Feb 08, 2021

SELL
$202.01 - $245.04 $2,222 - $2,695
-11 Reduced 0.86%
1,271 $311,000
Q1 2020

Apr 27, 2020

SELL
$126.5 - $225.1 $2,277 - $4,051
-18 Reduced 1.38%
1,282 $213,000
Q4 2019

Jan 24, 2020

SELL
$197.98 - $220.53 $2,969 - $3,307
-15 Reduced 1.14%
1,300 $273,000
Q2 2019

Aug 09, 2019

BUY
$180.24 - $205.58 $2,703 - $3,083
15 Added 1.15%
1,315 $270,000
Q1 2019

May 08, 2019

SELL
$152.46 - $198.0 $7,623 - $9,900
-50 Reduced 3.7%
1,300 $257,000
Q2 2018

Jul 27, 2018

SELL
$155.17 - $179.78 $11,637 - $13,483
-75 Reduced 5.26%
1,350 $228,000
Q1 2018

May 14, 2018

SELL
$148.01 - $168.91 $7,400 - $8,445
-50 Reduced 3.39%
1,425 $229,000
Q4 2017

Feb 14, 2018

BUY
$143.51 - $159.74 $211,677 - $235,616
1,475
1,475 $228,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $136B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.